160 related articles for article (PubMed ID: 32089426)
1. 3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors.
Peschiulli A; Oehlrich D; Rombouts F; Vos A; Gijsen HJ
Bioorg Med Chem Lett; 2020 Apr; 30(8):126999. PubMed ID: 32089426
[TBL] [Abstract][Full Text] [Related]
2. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.
Bowers S; Xu YZ; Yuan S; Probst GD; Hom RK; Chan W; Konradi AW; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
Bioorg Med Chem Lett; 2013 Apr; 23(7):2181-6. PubMed ID: 23465612
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).
Fernández-Bachiller MI; Horatscheck A; Lisurek M; Rademann J
ChemMedChem; 2013 Jul; 8(7):1041-56. PubMed ID: 23757181
[TBL] [Abstract][Full Text] [Related]
5. Potent pyrrolidine- and piperidine-based BACE-1 inhibitors.
Iserloh U; Wu Y; Cumming JN; Pan J; Wang LY; Stamford AW; Kennedy ME; Kuvelkar R; Chen X; Parker EM; Strickland C; Voigt J
Bioorg Med Chem Lett; 2008 Jan; 18(1):414-7. PubMed ID: 18023580
[TBL] [Abstract][Full Text] [Related]
6. Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors.
Jain P; Wadhwa PK; Rohilla S; Jadhav HR
Bioorg Med Chem Lett; 2016 Jan; 26(1):33-7. PubMed ID: 26614409
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors.
Xu YZ; Yuan S; Bowers S; Hom RK; Chan W; Sham HL; Zhu YL; Beroza P; Pan H; Brecht E; Yao N; Lougheed J; Yan J; Tam D; Ren Z; Ruslim L; Bova MP; Artis DR
Bioorg Med Chem Lett; 2013 May; 23(10):3075-80. PubMed ID: 23570791
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of BACE-1 inhibitors utilizing a tertiary hydroxyl motif as the transition state mimic.
Wångsell F; Russo F; Sävmarker J; Rosenquist A; Samuelsson B; Larhed M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4711-4. PubMed ID: 19576765
[TBL] [Abstract][Full Text] [Related]
10. Improving the permeability of the hydroxyethylamine BACE-1 inhibitors: structure-activity relationship of P2' substituents.
Truong AP; Probst GD; Aquino J; Fang L; Brogley L; Sealy JM; Hom RK; Tucker JA; John V; Tung JS; Pleiss MA; Konradi AW; Sham HL; Dappen MS; Tóth G; Yao N; Brecht E; Pan H; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Zmolek W; Quinn KP; Sauer JM
Bioorg Med Chem Lett; 2010 Aug; 20(16):4789-94. PubMed ID: 20634069
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.
Probst GD; Bowers S; Sealy JM; Stupi B; Dressen D; Jagodzinska BM; Aquino J; Gailunas A; Truong AP; Tso L; Xu YZ; Hom RK; John V; Tung JS; Pleiss MA; Tucker JA; Konradi AW; Sham HL; Jagodzinski J; Toth G; Brecht E; Yao N; Pan H; Lin M; Artis DR; Ruslim L; Bova MP; Sinha S; Yednock TA; Gauby S; Zmolek W; Quinn KP; Sauer JM
Bioorg Med Chem Lett; 2010 Oct; 20(20):6034-9. PubMed ID: 20822903
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro evaluation studies of sulfonyl-amino-acetamides as small molecule BACE-1 inhibitors.
Jain P; Wadhwa PK; Gunapati S; Jadhav HR
Bioorg Med Chem; 2016 Jun; 24(11):2567-2575. PubMed ID: 27102162
[TBL] [Abstract][Full Text] [Related]
13. Design and discovery of C2-fluoroalkyl iminothiazine dioxides as BACE inhibitors.
Taoka BM; Wu WL; Hao J; Dolmaski M; Wang H; Levorse D; Orth P; Hyde LA; Smith B; Michener MS; Kennedy ME; Parker EM; Cumming JN
Bioorg Med Chem Lett; 2022 Jan; 56():128463. PubMed ID: 34838652
[TBL] [Abstract][Full Text] [Related]
14. Computational methods in the discovery and design of BACE-1 inhibitors.
Kacker P; Bottegoni G; Cavalli A
Curr Med Chem; 2012; 19(36):6095-111. PubMed ID: 23072352
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
[TBL] [Abstract][Full Text] [Related]
16. Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features.
Shimmyo Y; Kihara T; Akaike A; Niidome T; Sugimoto H
Biochim Biophys Acta; 2008 May; 1780(5):819-25. PubMed ID: 18295609
[TBL] [Abstract][Full Text] [Related]
17. Human beta-secretase (BACE) and BACE inhibitors.
John V; Beck JP; Bienkowski MJ; Sinha S; Heinrikson RL
J Med Chem; 2003 Oct; 46(22):4625-30. PubMed ID: 14561080
[No Abstract] [Full Text] [Related]
18. Synthesis and SAR of indole-and 7-azaindole-1,3-dicarboxamide hydroxyethylamine inhibitors of BACE-1.
Marcin LR; Higgins MA; Zusi FC; Zhang Y; Dee MF; Parker MF; Muckelbauer JK; Camac DM; Morin PE; Ramamurthy V; Tebben AJ; Lentz KA; Grace JE; Marcinkeviciene JA; Kopcho LM; Burton CR; Barten DM; Toyn JH; Meredith JE; Albright CF; Bronson JJ; Macor JE; Thompson LA
Bioorg Med Chem Lett; 2011 Jan; 21(1):537-41. PubMed ID: 21078556
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors.
Liu J; Chen W; Xu Y; Ren S; Zhang W; Li Y
Bioorg Med Chem; 2015 May; 23(9):1963-74. PubMed ID: 25842365
[TBL] [Abstract][Full Text] [Related]
20. 4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies.
Liu P; Niu Y; Wang C; Sun Q; Zhai Y; Yu J; Sun J; Xu F; Yan G; Huang W; Liang L; Xu P
Eur J Med Chem; 2014 May; 79():413-21. PubMed ID: 24763262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
